KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 144 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $9,602 | -79.2% | 11,100 | -6.6% | 0.00% | -83.3% |
| Q1 2023 | $46,213 | -68.9% | 11,880 | -72.8% | 0.01% | -72.7% |
| Q4 2022 | $148,369 | -47.8% | 43,638 | +61.6% | 0.02% | -66.2% |
| Q1 2021 | $284,000 | +5.2% | 27,000 | +92.2% | 0.06% | +12.1% |
| Q1 2020 | $270,000 | +178.4% | 14,051 | +39.1% | 0.06% | +222.2% |
| Q3 2019 | $97,000 | – | 10,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |